AI Engines For more Details: Perplexity Kagi Labs You
Seizure Control: Oxcarbazepine is approved for the treatment of partial seizures in adults and children aged 4 years and older. It works by stabilizing electrical activity in the brain, which helps to prevent seizures from occurring.
Epilepsy Management: It is effective in reducing the frequency and severity of seizures in individuals with epilepsy. It may be used alone or in combination with other antiepileptic medications to achieve optimal seizure control.
Mood Stabilization: In addition to its anticonvulsant properties, oxcarbazepine has mood-stabilizing effects. It is sometimes prescribed off-label for the treatment of bipolar disorder to help stabilize mood swings and prevent manic episodes.
Off-Label Uses: While oxcarbazepine is primarily indicated for epilepsy and bipolar disorder, it may also be prescribed off-label for other conditions such as neuropathic pain, trigeminal neuralgia, and impulse control disorders.
Tolerability: Oxcarbazepine is generally well-tolerated, with fewer drug interactions compared to older anticonvulsant medications like carbamazepine. It has a lower risk of causing adverse effects on liver function and blood cell counts.
Side Effects: Common side effects of oxcarbazepine may include dizziness, drowsiness, headache, nausea, vomiting, fatigue, and double vision. These side effects are usually mild and transient, but they may require dose adjustments or discontinuation of the medication in some cases.
Serious Side Effects: Although rare, oxcarbazepine can cause more serious side effects such as allergic reactions, including rash, fever, swollen glands, and liver problems. It may also increase the risk of suicidal thoughts or behaviors, especially in individuals with a history of depression or mood disorders.
Drug Interactions: Oxcarbazepine may interact with certain medications, including other antiepileptic drugs, oral contraceptives, and antidepressants. It is important for healthcare providers to review all medications a patient is taking to avoid potential interactions.
Pregnancy and Breastfeeding: Oxcarbazepine may pose risks to pregnant women and their developing fetuses. Women of childbearing age should use effective contraception while taking oxcarbazepine, and pregnant women should discuss the risks and benefits of the medication with their healthcare provider.
Monitoring: Regular monitoring of liver function tests and blood cell counts may be recommended during long-term treatment with oxcarbazepine to detect any potential adverse effects.
Discontinuation: Abrupt discontinuation of oxcarbazepine should be avoided, as it may lead to increased seizure activity or withdrawal symptoms. Dosage should be gradually tapered under medical supervision when discontinuing treatment.
Rank | Probiotic | Impact |
---|---|---|
genus | Bifidobacterium | Reduces |
species | Akkermansia muciniphila | Reduces |
species | Anaerobutyricum hallii | Reduces |
species | Bacteroides uniformis | Reduces |
species | Bifidobacterium adolescentis | Reduces |
species | Bifidobacterium bifidum | Reduces |
species | Bifidobacterium breve | Reduces |
species | Bifidobacterium catenulatum | Reduces |
species | Bifidobacterium longum | Reduces |
species | Blautia wexlerae | Reduces |
species | Christensenella minuta | Reduces |
species | Enterococcus faecium | Reduces |
species | Escherichia coli | Reduces |
species | Faecalibacterium prausnitzii | Reduces |
species | Lactococcus cremoris | Reduces |
species | Parabacteroides distasonis | Reduces |
species | Veillonella atypica | Reduces |
subspecies | Bifidobacterium longum subsp. infantis | Reduces |
subspecies | Bifidobacterium longum subsp. longum | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
π Direct Citations | πͺπΆ Indirect Citations | Taxonomy | Rank | Effect |
---|---|---|---|---|
0 | 1 | Akkermansiaceae | family | Decreases |
0 | 1 | Collinsella | genus | Decreases |
0 | 1 | Enterocloster | genus | Decreases |
0 | 1 | Veillonella | genus | Decreases |
0 | 1 | Thomasclavelia | genus | Decreases |
0 | 1 | Dorea | genus | Decreases |
0 | 1 | Blautia | genus | Decreases |
0 | 1 | Roseburia | genus | Decreases |
0 | 1 | Lacrimispora | genus | Decreases |
0 | 1 | Bifidobacterium | genus | Decreases |
0 | 1 | Odoribacter | genus | Decreases |
0 | 1 | Eggerthella | genus | Decreases |
0 | 1 | Phocaeicola | genus | Decreases |
1 | 0 | Akkermansia | genus | Decreases |
0 | 1 | Lachnospira | genus | Decreases |
0 | 1 | Bacteroides | genus | Decreases |
0 | 1 | Clostridioides | genus | Decreases |
0 | 1 | Clostridium | genus | Decreases |
0 | 1 | Coprococcus | genus | Decreases |
0 | 1 | Ruminococcus | genus | Decreases |
0 | 1 | Streptococcus | genus | Decreases |
0 | 1 | Parabacteroides | genus | Decreases |
0 | 1 | Parolsenella | genus | Decreases |
0 | 1 | Agathobacter | genus | Decreases |
0 | 1 | Flavonifractor | genus | Decreases |
0 | 1 | Fusobacterium | genus | Decreases |
0 | 1 | Escherichia | genus | Decreases |
0 | 1 | Anaerobutyricum | genus | Decreases |
0 | 1 | Wansuia | genus | Decreases |
0 | 1 | Mediterraneibacter | genus | Decreases |
0 | 1 | Segatella | genus | Decreases |
0 | 1 | Clostridium perfringens A | no rank | Decreases |
0 | 1 | Clostridium perfringens B | no rank | Decreases |
0 | 1 | Clostridium perfringens C | no rank | Decreases |
0 | 1 | Clostridium perfringens CPE | no rank | Decreases |
0 | 1 | Clostridium perfringens D | no rank | Decreases |
0 | 1 | Clostridium perfringens E | no rank | Decreases |
0 | 1 | environmental samples | no rank | Decreases |
0 | 1 | unclassified Akkermansia | no rank | Decreases |
0 | 1 | Escherichia coli O1:K1:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O139:H1 | no rank | Decreases |
0 | 1 | Escherichia coli O141:H4 | no rank | Decreases |
0 | 1 | Escherichia coli O145:H34 | no rank | Decreases |
0 | 1 | Escherichia coli O15:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O155:H21 | no rank | Decreases |
0 | 1 | Escherichia coli O158:H23 | no rank | Decreases |
0 | 1 | Escherichia coli O16:H48 | no rank | Decreases |
0 | 1 | Escherichia coli O170:H18 | no rank | Decreases |
0 | 1 | Escherichia coli O18ac:H14 | no rank | Decreases |
0 | 1 | Escherichia coli O19:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H4 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H5 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O20:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O25:H16 | no rank | Decreases |
0 | 1 | Escherichia coli O55:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O68:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O7:H15 | no rank | Decreases |
0 | 1 | Escherichia coli O78:H51 | no rank | Decreases |
0 | 1 | Escherichia coli O80:H26 | no rank | Decreases |
0 | 1 | Escherichia coli O84:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O85:H1 | no rank | Decreases |
0 | 1 | Escherichia coli O103 | serogroup | Decreases |
0 | 1 | Escherichia coli O111 | serogroup | Decreases |
0 | 1 | Escherichia coli O119 | serogroup | Decreases |
0 | 1 | Escherichia coli O121 | serogroup | Decreases |
0 | 1 | Escherichia coli O145 | serogroup | Decreases |
0 | 1 | Escherichia coli O155 | serogroup | Decreases |
0 | 1 | Escherichia coli O157 | serogroup | Decreases |
0 | 1 | Escherichia coli O177 | serogroup | Decreases |
0 | 1 | Escherichia coli O26 | serogroup | Decreases |
0 | 1 | Escherichia coli O3 | serogroup | Decreases |
0 | 1 | Escherichia coli O43 | serogroup | Decreases |
0 | 1 | Escherichia coli O5 | serogroup | Decreases |
0 | 1 | Escherichia coli O78 | serogroup | Decreases |
0 | 1 | Escherichia coli O86 | serogroup | Decreases |
0 | 1 | Escherichia coli O91 | serogroup | Decreases |
0 | 1 | Escherichia coli H20 | serotype | Decreases |
0 | 1 | Escherichia coli O1:H42 | serotype | Decreases |
0 | 1 | Escherichia coli O1:HNT | serotype | Decreases |
0 | 1 | Escherichia coli O10:H32 | serotype | Decreases |
0 | 1 | Escherichia coli O10:K5(L):H4 | serotype | Decreases |
0 | 1 | Escherichia coli O100:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O104:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O104:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H- | serotype | Decreases |
0 | 1 | Escherichia coli O111:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O111:NM | serotype | Decreases |
0 | 1 | Escherichia coli O112ab:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O112ac:H19 | serotype | Decreases |
0 | 1 | Escherichia coli O113:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O114:H49 | serotype | Decreases |
0 | 1 | Escherichia coli O118:H16 | serotype | Decreases |
0 | 1 | Escherichia coli O121:H19 | serotype | Decreases |
0 | 1 | Escherichia coli O121:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O123:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O125ac:K+:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O126:H45 | serotype | Decreases |
0 | 1 | Escherichia coli O127:H27 | serotype | Decreases |
0 | 1 | Escherichia coli O127:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O128:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O128ac:H12 | serotype | Decreases |
0 | 1 | Escherichia coli O139:H28 | serotype | Decreases |
0 | 1 | Escherichia coli O145:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O145:H28 | serotype | Decreases |
0 | 1 | Escherichia coli O145:NM | serotype | Decreases |
0 | 1 | Escherichia coli O146:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O15:H18 | serotype | Decreases |
0 | 1 | Escherichia coli O150:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O152:H23 | serotype | Decreases |
0 | 1 | Escherichia coli O153:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O156:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H- | serotype | Decreases |
0 | 1 | Escherichia coli O157:H43 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O157:NM | serotype | Decreases |
0 | 1 | Escherichia coli O16:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O165:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O167:H26 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O176:H45 | serotype | Decreases |
0 | 1 | Escherichia coli O177:NM | serotype | Decreases |
0 | 1 | Escherichia coli O2:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O2:K2:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O25:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O25:NM | serotype | Decreases |
0 | 1 | Escherichia coli O26:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O26:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O28ac:NM | serotype | Decreases |
0 | 1 | Escherichia coli O29:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O32:H37 | serotype | Decreases |
0 | 1 | Escherichia coli O39:NM | serotype | Decreases |
0 | 1 | Escherichia coli O44:H18 | serotype | Decreases |
0 | 1 | Escherichia coli O45:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O6:H16 | serotype | Decreases |
0 | 1 | Escherichia coli O6:H16:CFA/II | serotype | Decreases |
0 | 1 | Escherichia coli O6:K2:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O69:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O7:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O7:K1 | serotype | Decreases |
0 | 1 | Escherichia coli O78:H12 | serotype | Decreases |
0 | 1 | Escherichia coli O78:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O79:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O8:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O81:NM | serotype | Decreases |
0 | 1 | Escherichia coli O83:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O86:H34 | serotype | Decreases |
0 | 1 | Escherichia coli O89m:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O89m:H9 | serotype | Decreases |
0 | 1 | Escherichia coli O9:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O91:H14 | serotype | Decreases |
0 | 1 | Escherichia coli O91:NM | serotype | Decreases |
0 | 1 | Escherichia coli O99:H6 | serotype | Decreases |
0 | 1 | Escherichia coli ONT:H33 | serotype | Decreases |
1 | 0 | Odoribacter splanchnicus | species | Decreases |
1 | 0 | Eggerthella lenta | species | Decreases |
1 | 0 | Phocaeicola vulgatus | species | Decreases |
1 | 0 | Akkermansia muciniphila | species | Decreases |
1 | 0 | Bacteroides fragilis | species | Decreases |
1 | 0 | Bacteroides thetaiotaomicron | species | Decreases |
1 | 0 | Bifidobacterium adolescentis | species | Decreases |
1 | 0 | Blautia obeum | species | Decreases |
1 | 0 | Collinsella aerofaciens | species | Decreases |
1 | 0 | Dorea formicigenerans | species | Decreases |
1 | 0 | Enterocloster bolteae | species | Decreases |
1 | 0 | Lacrimispora saccharolytica | species | Decreases |
1 | 0 | Roseburia hominis | species | Decreases |
1 | 0 | Thomasclavelia ramosa | species | Decreases |
1 | 0 | Veillonella parvula | species | Decreases |
1 | 0 | Streptococcus parasanguinis | species | Decreases |
1 | 0 | Lachnospira eligens | species | Decreases |
1 | 0 | Clostridioides difficile | species | Decreases |
1 | 0 | Bifidobacterium longum | species | Decreases |
1 | 0 | Bacteroides ovatus | species | Decreases |
1 | 0 | Clostridium perfringens | species | Decreases |
1 | 0 | Coprococcus comes | species | Decreases |
1 | 0 | Ruminococcus bromii | species | Decreases |
1 | 0 | Bacteroides caccae | species | Decreases |
1 | 0 | Bacteroides uniformis | species | Decreases |
1 | 0 | Parabacteroides distasonis | species | Decreases |
1 | 0 | [Ruminococcus] torques | species | Decreases |
1 | 0 | Parabacteroides merdae | species | Decreases |
1 | 0 | Agathobacter rectalis | species | Decreases |
0 | 1 | Veillonella rodentium | species | Decreases |
0 | 1 | Streptococcus sp. LPB0220 | species | Decreases |
0 | 1 | Streptococcus sp. HSISM1 | species | Decreases |
1 | 0 | Fusobacterium nucleatum | species | Decreases |
0 | 1 | Eggerthella guodeyinii | species | Decreases |
0 | 1 | Veillonella dispar | species | Decreases |
0 | 1 | Coprococcus catus | species | Decreases |
1 | 0 | Streptococcus salivarius | species | Decreases |
1 | 0 | Escherichia coli | species | Decreases |
0 | 1 | Dorea longicatena | species | Decreases |
0 | 1 | Veillonella sp. S12025-13 | species | Decreases |
0 | 1 | Anaerobutyricum hallii | species | Decreases |
1 | 0 | Bacteroides xylanisolvens | species | Decreases |
0 | 1 | Veillonella nakazawae | species | Decreases |
0 | 1 | Wansuia hejianensis | species | Decreases |
0 | 1 | Bifidobacterium angulatum | species | Decreases |
0 | 1 | Blautia sp. SC05B48 | species | Decreases |
0 | 1 | Bifidobacterium breve | species | Decreases |
0 | 1 | Komagataeibacter oboediens | species | Decreases |
0 | 1 | Parolsenella catena | species | Decreases |
0 | 1 | Ligilactobacillus ruminis | species | Decreases |
0 | 1 | Butyrivibrio crossotus | species | Decreases |
0 | 1 | Subdoligranulum variabile | species | Decreases |
0 | 1 | Eubacterium ventriosum | species | Decreases |
0 | 1 | Streptococcus sp. FDAARGOS_192 | species | Decreases |
0 | 1 | Veillonella rogosae | species | Decreases |
0 | 1 | Clostridium sp. M62/1 | species | Decreases |
0 | 1 | Parolsenella massiliensis | species | Decreases |
0 | 1 | Eubacterium sp. MSJ-33 | species | Decreases |
0 | 1 | Clostridium sp. SY8519 | species | Decreases |
0 | 1 | Blautia liquoris | species | Decreases |
0 | 1 | Faecalibacillus intestinalis | species | Decreases |
0 | 1 | Flavonifractor plautii | species | Decreases |
0 | 1 | Alistipes megaguti | species | Decreases |
0 | 1 | Qiania dongpingensis | species | Decreases |
0 | 1 | Faecalibacterium duncaniae | species | Decreases |
0 | 1 | Coprococcus eutactus | species | Decreases |
0 | 1 | Faecalitalea cylindroides | species | Decreases |
0 | 1 | [Ruminococcus] lactaris | species | Decreases |
0 | 1 | Novisyntrophococcus fermenticellae | species | Decreases |
0 | 1 | Christensenella minuta | species | Decreases |
0 | 1 | Collinsella stercoris | species | Decreases |
0 | 1 | Wujia chipingensis | species | Decreases |
0 | 1 | Vescimonas fastidiosa | species | Decreases |
0 | 1 | Bacteroides sp. CACC 737 | species | Decreases |
0 | 1 | Intestinibaculum porci | species | Decreases |
0 | 1 | Massilistercora timonensis | species | Decreases |
0 | 1 | Pseudobutyrivibrio xylanivorans | species | Decreases |
0 | 1 | Maliibacterium massiliense | species | Decreases |
0 | 1 | Catenibacterium mitsuokai | species | Decreases |
0 | 1 | Roseburia rectibacter | species | Decreases |
0 | 1 | Coprobacter fastidiosus | species | Decreases |
0 | 1 | [Clostridium] hylemonae | species | Decreases |
0 | 1 | Adlercreutzia equolifaciens | species | Decreases |
0 | 1 | Anaerostipes hadrus | species | Decreases |
0 | 1 | Veillonella atypica | species | Decreases |
0 | 1 | Lachnoanaerobaculum gingivalis | species | Decreases |
0 | 1 | Bacteroides luhongzhouii | species | Decreases |
0 | 1 | Ruminococcus champanellensis | species | Decreases |
0 | 1 | Coprococcus sp. ART55/1 | species | Decreases |
0 | 1 | Ruminococcus gauvreauii | species | Decreases |
0 | 1 | Faecalibacterium sp. I2-3-92 | species | Decreases |
0 | 1 | Marvinbryantia formatexigens | species | Decreases |
0 | 1 | Fannyhessea vaginae | species | Decreases |
0 | 1 | Vescimonas coprocola | species | Decreases |
0 | 1 | Ruminococcus bicirculans (ex Wegman et al. 2014) | species | Decreases |
0 | 1 | Lachnoclostridium phocaeense | species | Decreases |
0 | 1 | Actinomyces naeslundii | species | Decreases |
0 | 1 | Faecalibacterium sp. I4-1-79 | species | Decreases |
0 | 1 | Longicatena caecimuris | species | Decreases |
0 | 1 | Bacillus paralicheniformis | species | Decreases |
0 | 1 | Clostridium cadaveris | species | Decreases |
0 | 1 | Simiaoa sunii | species | Decreases |
0 | 1 | Catenibacterium sp. co_0103 | species | Decreases |
0 | 1 | Roseburia intestinalis | species | Decreases |
0 | 1 | Alistipes sp. dk3624 | species | Decreases |
0 | 1 | Faecalibacterium sp. IP-3-29 | species | Decreases |
0 | 1 | Treponema peruense | species | Decreases |
0 | 1 | Alistipes onderdonkii | species | Decreases |
0 | 1 | Monoglobus pectinilyticus | species | Decreases |
0 | 1 | Bacteroides sp. D2 | species | Decreases |
0 | 1 | Faecalibacterium sp. HTF-F | species | Decreases |
0 | 1 | Streptococcus suis | species | Decreases |
0 | 1 | Hungatella hathewayi | species | Decreases |
0 | 1 | Olsenella sp. oral taxon 807 | species | Decreases |
0 | 1 | Bacteroides sp. A1C1 | species | Decreases |
0 | 1 | Actinomyces oris | species | Decreases |
0 | 1 | Alistipes finegoldii | species | Decreases |
0 | 1 | Faecalibacterium sp. I3-3-33 | species | Decreases |
0 | 1 | Faecalibacterium sp. IP-1-18 | species | Decreases |
0 | 1 | uncultured Alistipes sp. | species | Decreases |
0 | 1 | Faecalibacterium sp. I4-3-84 | species | Decreases |
0 | 1 | Mageeibacillus indolicus | species | Decreases |
0 | 1 | Solibaculum mannosilyticum | species | Decreases |
0 | 1 | Lactococcus cremoris | species | Decreases |
0 | 1 | Streptococcus lactarius | species | Decreases |
0 | 1 | Bifidobacterium catenulatum | species | Decreases |
0 | 1 | Oscillibacter hominis | species | Decreases |
0 | 1 | Faecalibacterium sp. I3-3-89 | species | Decreases |
0 | 1 | Parvimonas micra | species | Decreases |
0 | 1 | Mogibacterium diversum | species | Decreases |
0 | 1 | Adlercreutzia hattorii | species | Decreases |
0 | 1 | Flintibacter sp. KGMB00164 | species | Decreases |
0 | 1 | Butyricimonas virosa | species | Decreases |
0 | 1 | Intestinimonas butyriciproducens | species | Decreases |
0 | 1 | Eubacterium limosum | species | Decreases |
0 | 1 | Enterocloster clostridioformis | species | Decreases |
0 | 1 | Eubacterium sp. c-25 | species | Decreases |
0 | 1 | Ruminococcus albus | species | Decreases |
0 | 1 | Streptococcus gordonii | species | Decreases |
0 | 1 | Alistipes ihumii | species | Decreases |
0 | 1 | Bacteroides sp. M10 | species | Decreases |
0 | 1 | Blautia wexlerae | species | Decreases |
0 | 1 | Corynebacterium durum | species | Decreases |
0 | 1 | Bacteroides sp. DH3716P | species | Decreases |
0 | 1 | Bacteroides nordii | species | Decreases |
0 | 1 | Acutalibacter muris | species | Decreases |
0 | 1 | Eubacterium callanderi | species | Decreases |
0 | 1 | Ruthenibacterium lactatiformans | species | Decreases |
0 | 1 | Parafannyhessea umbonata | species | Decreases |
0 | 1 | Faecalibacterium prausnitzii | species | Decreases |
0 | 1 | Phoenicibacter congonensis | species | Decreases |
0 | 1 | Lawsonibacter asaccharolyticus | species | Decreases |
0 | 1 | Alistipes communis | species | Decreases |
0 | 1 | Barnesiella viscericola | species | Decreases |
0 | 1 | Alistipes senegalensis | species | Decreases |
0 | 1 | [Eubacterium] hominis | species | Decreases |
0 | 1 | Treponema denticola | species | Decreases |
0 | 1 | Eubacterium maltosivorans | species | Decreases |
0 | 1 | Chordicoccus furentiruminis | species | Decreases |
0 | 1 | Enterococcus cecorum | species | Decreases |
0 | 1 | Enterococcus faecium | species | Decreases |
0 | 1 | Actinomyces sp. oral taxon 169 | species | Decreases |
0 | 1 | Anaerotruncus colihominis | species | Decreases |
0 | 1 | Ruminococcus bovis | species | Decreases |
0 | 1 | Faecalibaculum rodentium | species | Decreases |
0 | 1 | Pusillibacter faecalis | species | Decreases |
0 | 1 | Alistipes dispar | species | Decreases |
0 | 1 | Bifidobacterium bifidum | species | Decreases |
0 | 1 | Coprobacter secundus | species | Decreases |
0 | 1 | Alistipes shahii | species | Decreases |
0 | 1 | Gordonibacter urolithinfaciens | species | Decreases |
0 | 1 | Streptococcus vestibularis | species | Decreases |
0 | 1 | Phascolarctobacterium succinatutens | species | Decreases |
0 | 1 | Bacteroides humanifaecis | species | Decreases |
0 | 1 | Bacteroides sp. HF-162 | species | Decreases |
0 | 1 | Streptococcus australis | species | Decreases |
0 | 1 | Shigella dysenteriae | species | Decreases |
0 | 1 | Actinomyces sp. oral taxon 171 | species | Decreases |
0 | 1 | Amedibacterium intestinale | species | Decreases |
0 | 1 | Phascolarctobacterium sp. Marseille-Q4147 | species | Decreases |
0 | 1 | Romboutsia ilealis | species | Decreases |
0 | 1 | Bacteroides cellulosilyticus | species | Decreases |
0 | 1 | Streptococcus mutans | species | Decreases |
0 | 1 | Streptococcus sp. oral taxon 061 | species | Decreases |
0 | 1 | Shigella flexneri | species | Decreases |
0 | 1 | Clostridium sp. C1 | species | Decreases |
0 | 1 | Butyricicoccus sp. GAM44 | species | Decreases |
0 | 1 | Butyrivibrio fibrisolvens | species | Decreases |
0 | 1 | Escherichia albertii | species | Decreases |
0 | 1 | Emergencia timonensis | species | Decreases |
0 | 1 | Arabiibacter massiliensis | species | Decreases |
0 | 1 | Alistipes indistinctus | species | Decreases |
0 | 1 | Akkermansia glycaniphila | species | Decreases |
0 | 1 | Akkermansia massiliensis | species | Decreases |
0 | 1 | Candidatus Akkermansia intestinavium | species | Decreases |
0 | 1 | Streptococcus infantis | species | Decreases |
1 | 0 | Segatella copri | species | Decreases |
1 | 0 | Mediterraneibacter gnavus | species | Decreases |
0 | 1 | Bifidobacterium longum subsp. infantis | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. longum | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. suillum | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. suis | subspecies | Decreases |
0 | 1 | Fusobacterium nucleatum subsp. nucleatum | subspecies | Decreases |
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Abdominal Aortic Aneurysm | 0.6 | 0.6 | |
Acne | 0.3 | -0.3 | |
ADHD | 4 | 0.9 | 3.44 |
Age-Related Macular Degeneration and Glaucoma | 0.9 | 0.2 | 3.5 |
Allergic Rhinitis (Hay Fever) | 2.4 | 3.2 | -0.33 |
Allergies | 7 | 3.4 | 1.06 |
Allergy to milk products | 2.3 | 1.1 | 1.09 |
Alopecia (Hair Loss) | 1.6 | 0.1 | 15 |
Alzheimer's disease | 6.3 | 6.5 | -0.03 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 3.7 | 1.2 | 2.08 |
Ankylosing spondylitis | 4.1 | 1 | 3.1 |
Anorexia Nervosa | 1.6 | 3.2 | -1 |
Antiphospholipid syndrome (APS) | 1.2 | 1.2 | |
Asthma | 5.7 | 3.2 | 0.78 |
Atherosclerosis | 2.6 | 1.8 | 0.44 |
Atrial fibrillation | 3.8 | 1.3 | 1.92 |
Autism | 10 | 9.4 | 0.06 |
Autoimmune Disease | 0.7 | 1 | -0.43 |
Barrett esophagus cancer | 0.5 | 0.2 | 1.5 |
benign prostatic hyperplasia | 0.1 | 0.3 | -2 |
Biofilm | 1.9 | 1.9 | |
Bipolar Disorder | 1.6 | 1.6 | 0 |
Brain Trauma | 1.1 | 1.3 | -0.18 |
Breast Cancer | 0.5 | 0.5 | |
Cancer (General) | 0.9 | 2.4 | -1.67 |
Carcinoma | 3.6 | 2.6 | 0.38 |
Celiac Disease | 3.3 | 3.7 | -0.12 |
Cerebral Palsy | 1.8 | 1.3 | 0.38 |
Chronic Fatigue Syndrome | 5.9 | 7 | -0.19 |
Chronic Kidney Disease | 3.9 | 2.8 | 0.39 |
Chronic Lyme | 0.6 | 0.6 | 0 |
Chronic Obstructive Pulmonary Disease (COPD) | 2.2 | 1.6 | 0.38 |
Chronic Urticaria (Hives) | 1.2 | 1.4 | -0.17 |
Coagulation / Micro clot triggering bacteria | 0.7 | 1.2 | -0.71 |
Cognitive Function | 2.1 | 1.5 | 0.4 |
Colorectal Cancer | 6.5 | 2.5 | 1.6 |
Constipation | 1.5 | 0.7 | 1.14 |
Coronary artery disease | 1.6 | 3.4 | -1.13 |
COVID-19 | 11.7 | 14.2 | -0.21 |
Crohn's Disease | 8 | 6.6 | 0.21 |
Cushing's Syndrome (hypercortisolism) | 0.9 | -0.9 | |
cystic fibrosis | 0.3 | 2 | -5.67 |
d-lactic acidosis (one form of brain fog) | 0.2 | 0.2 | |
deep vein thrombosis | 1.7 | 1.1 | 0.55 |
Denture Wearers Oral Shifts | 1.5 | 1.5 | |
Depression | 11.8 | 9.1 | 0.3 |
Dermatomyositis | 0.2 | 0.3 | -0.5 |
Eczema | 1.2 | 2.2 | -0.83 |
Endometriosis | 2.5 | 2.1 | 0.19 |
Eosinophilic Esophagitis | 0.1 | 0.6 | -5 |
Epilepsy | 3.9 | 2.4 | 0.63 |
erectile dysfunction | 0.8 | 0.3 | 1.67 |
Fibromyalgia | 3.8 | 2 | 0.9 |
Functional constipation / chronic idiopathic constipation | 5.1 | 3.9 | 0.31 |
gallstone disease (gsd) | 2.9 | 1.1 | 1.64 |
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 2.1 | 1.8 | 0.17 |
Generalized anxiety disorder | 2.2 | 2.2 | 0 |
giant cell arteritis | 0.3 | -0.3 | |
Glioblastoma | 0.2 | -0.2 | |
Gout | 1.7 | 0.8 | 1.13 |
Graves' disease | 1.9 | 3.3 | -0.74 |
Gulf War Syndrome | 1.1 | 2.5 | -1.27 |
Halitosis | 1.3 | 0.2 | 5.5 |
Hashimoto's thyroiditis | 4 | 1.7 | 1.35 |
Heart Failure | 3.3 | 2.3 | 0.43 |
hemorrhagic stroke | 0.7 | 0.7 | |
Hidradenitis Suppurativa | 0.9 | 0.4 | 1.25 |
High Histamine/low DAO | 1.4 | 0.6 | 1.33 |
hypercholesterolemia (High Cholesterol) | 0.8 | 0.7 | 0.14 |
hyperglycemia | 1.4 | 2.2 | -0.57 |
Hyperlipidemia (High Blood Fats) | 1.1 | 0.4 | 1.75 |
hypersomnia | 0.1 | 0.8 | -7 |
hypertension (High Blood Pressure | 4.4 | 6.5 | -0.48 |
Hypothyroidism | 0.4 | 1.3 | -2.25 |
Hypoxia | 2.3 | 2.3 | |
IgA nephropathy (IgAN) | 1.4 | 4.6 | -2.29 |
Inflammatory Bowel Disease | 9.1 | 9.9 | -0.09 |
Insomnia | 2.4 | 3.3 | -0.38 |
Intelligence | 1.7 | 0.2 | 7.5 |
Intracranial aneurysms | 1.2 | 0.8 | 0.5 |
Irritable Bowel Syndrome | 7.6 | 5.8 | 0.31 |
ischemic stroke | 2.8 | 1 | 1.8 |
Liver Cirrhosis | 6.9 | 4.1 | 0.68 |
Long COVID | 8.2 | 8.6 | -0.05 |
Low bone mineral density | 1.2 | -1.2 | |
Lung Cancer | 0.6 | 2.1 | -2.5 |
Lymphoma | 0.1 | 0.1 | |
Mast Cell Issues / mastitis | 0.6 | 0.8 | -0.33 |
ME/CFS with IBS | 1.1 | 3.1 | -1.82 |
ME/CFS without IBS | 1.6 | 2.2 | -0.38 |
membranous nephropathy | 0.2 | 0.2 | |
Menopause | 2.3 | 0.8 | 1.87 |
Metabolic Syndrome | 6.8 | 8.8 | -0.29 |
Mood Disorders | 12.2 | 7.6 | 0.61 |
multiple chemical sensitivity [MCS] | 1.1 | 0.5 | 1.2 |
Multiple Sclerosis | 7.5 | 6 | 0.25 |
Multiple system atrophy (MSA) | 2.2 | 1 | 1.2 |
myasthenia gravis | 0.3 | 0.6 | -1 |
neuropathic pain | 0.3 | 3 | -9 |
Neuropathy (all types) | 1.2 | 1.4 | -0.17 |
neuropsychiatric disorders (PANDAS, PANS) | 0.8 | 0.8 | |
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 5.1 | 5.8 | -0.14 |
NonCeliac Gluten Sensitivity | 2.4 | 0.6 | 3 |
Obesity | 10.4 | 8.2 | 0.27 |
obsessive-compulsive disorder | 5.9 | 3.4 | 0.74 |
Osteoarthritis | 2.8 | 1.6 | 0.75 |
Osteoporosis | 2 | 2.1 | -0.05 |
pancreatic cancer | 0.8 | 0.2 | 3 |
Parkinson's Disease | 9 | 6.9 | 0.3 |
Polycystic ovary syndrome | 5.8 | 3.2 | 0.81 |
Postural orthostatic tachycardia syndrome | 0.3 | 0.6 | -1 |
Premenstrual dysphoric disorder | 1.2 | 0.2 | 5 |
primary biliary cholangitis | 1 | 1.5 | -0.5 |
Primary sclerosing cholangitis | 3 | 2.8 | 0.07 |
Psoriasis | 4.2 | 2.4 | 0.75 |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 6.8 | 4.6 | 0.48 |
Rosacea | 1.1 | 0.7 | 0.57 |
Schizophrenia | 7.9 | 3.3 | 1.39 |
scoliosis | 0.7 | 0.8 | -0.14 |
sensorineural hearing loss | 0.3 | 0.3 | |
Sjögren syndrome | 2.5 | 2.9 | -0.16 |
Sleep Apnea | 1.7 | 1.6 | 0.06 |
Slow gastric motility / Gastroparesis | 1.1 | 0.3 | 2.67 |
Small Intestinal Bacterial Overgrowth (SIBO) | 1.9 | 0.5 | 2.8 |
Stress / posttraumatic stress disorder | 2.5 | 3.2 | -0.28 |
Systemic Lupus Erythematosus | 3.7 | 2.6 | 0.42 |
Tic Disorder | 1.4 | 1.6 | -0.14 |
Tourette syndrome | 0.9 | 0.3 | 2 |
Type 1 Diabetes | 4.6 | 4.2 | 0.1 |
Type 2 Diabetes | 8.4 | 7.7 | 0.09 |
Ulcerative colitis | 6.1 | 7.7 | -0.26 |
Unhealthy Ageing | 5.1 | 2.2 | 1.32 |
Vitiligo | 2.1 | 1.7 | 0.24 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]